• 1
    Wagner JL, Behney CJ, Tunis SR, Ching A. Cost-effectiveness of colorectal cancer screening in average risk adults. Office of Technology Assessment, United States Congress. BP-H-146. April 1995.
  • 2
    Devesa SS, Chow WH. Variation in colorectal cancer incidence in the United States by subsite of origin. Cancer 1993; 71: 3819-26.
  • 3
    Offerhaus GJA, Giardello FM, Tersmette KWF, Mulder JWR, Tersmette AC, Moore A, Hamilton SR. Ethnic differences in the anatomical location of colorectal adenomatous polyps. Int J Cancer 1991; 49: 641-4.
  • 4
    Dodging UW, Cay NE, Muir CS, Barclay THC, Foster BAH, Gaseously DJ, et al. The distribution of cancer within the large bowel. Int J Cancer 1972; 10: 463-77.
  • 5
    Butcher D, Hassanein K, Dudgeon M, Rhodes J, Holmes FF. Female gender is a major determinant of changing subsite distribution of colorectal cancer with age. Cancer 1985: 714-6.
  • 6
    Thomas CR, Jarosz R, Evans N. Racial differences in the anatomical distribution of colon cancer. Arch Surg 1992; 127: 1241-5.
  • 7
    Coates RJ, Greenberg RS, Liu MT, Correa P, Harlan LC, Reyn olds P, et al. Anatomic site distribution of colon cancer by race and other colon cancer risk factors. Dis Colon Rectum 1995; 38: 42-50.
  • 8
    Beart RW. Colon cancer. In: SteeleGD, WinchesterDP, MenckHR, MurphyGP. National Cancer Data Base. Atlanta: American Cancer Society, 1992.
  • 9
    Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. New Engl J Med 1993; 329: 1977-81.
  • 10
    Trends in cancer screening. Morbid Mortal Weekly Rapt 1996; 45: 57-61.
  • 11
    Screening for colorectal cancer: United States, 1992-1993, and new guidelines. Morbid Mortal Weekly Rapt 1996; 45: 107-10.
  • 12
    Kuczmarski RJ, Flegal KM, Campbell AM, Johnson CL. Increasing prevalence of overweight among US adults. JAMA 1994; 272: 205-11.
  • 13
    Kumanyika S. Obesity in black women. Epidemiol Rev 1987; 9: 31-50.
  • 14
    Siiteri P. Adipose tissue as a source of hormones. Am J Clin Nutr 1987; 45: 277-82.
  • 15
    Calle EE, Miracle-McMahill HL, Thun MJ, Health CW Jr.. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst 1995; 87: 517-23.
  • 16
    Chute CS, Willett WC, Colditz GA, Stampfer MJ, Rosner B, Speizer FE. A prospective study of reproductive history and exogenous estrogens on the risk of colorectal cancer in women. Epidemiology 1991; 2: 201-7.
  • 17
    Furner SE, Davis FG, Nelson RL, Haenszel W. A case-control study of large bowel cancer and hormone exposure in women. Cancer Res 1989; 49: 4936-40.
  • 18
    Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long term morbidity and mortality of overweight adolescents: a follow up of the Harvard growth study of 1922 to 1935. N Engl J Med 1992; 327: 1350-5.
  • 19
    Kreger BE, Anderson KM, Schatzkin A, Splansky GL. Serum cholesterol level, body mass index and the risk of colon cancer. Cancer 1992; 70: 1038-43.
  • 20
    Blot WJ, Devesa SS, Kneller RW, Fraumeni JF. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-9.
  • 21
    Nelson RL, Persky V. The rise and fall of colorectal cancer. Dis Colon Rectum 1994; 37: 1175-6.
  • 22
    Mayberry RM, Coats RJ, Hill HA, Click LA, Chen V, Austin DF, et al. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst 1995; 87: 1686-93.
  • 23
    Gloecker LA, Schatzkin A, Kaplan R. Colon and rectum. In: MillerBA, GloeckerLA, HankleyBF, KosaryCL, HarrasA, DevesaSS, EdwardsBK, editors. SEER cancer statistics review 1973-1990. DHSS publication no. 93-2789. 1993: VI.1-VI.10.
  • 24
    Wolmark N, Wieand HS, Rockette HE. The prognostic significance of tumor and location and bowel obstruction in Dukes' B and C colorectal cancer: findings from the NSABP clinical trials. Ann Surg 1983; 198: 743-52.